Search
Apimeds Pharmaceuticals US Inc
APUSAdd to Watchlist
1.850USD
+0.180+10.78%
Close 09-22 16:00（ET）
2.79MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+10.78%
5 Days
+12.80%
1 Month
-61.78%
6 Months
-99.10%
Year to Date
-98.87%
1 Year
-99.06%
Key Figures
1.650Open
1.999High
17.77KVolume
LossP/E TTM
0.00P/E Dynamic
--Dividend TTM
1.18%Turnover Ratio
1.670Prev. Close
1.613Low
30.91KTurnover
LossP/E Static
0.03P/B
0.00%Div Yield TTM
-7.31%ROA
8.27552wk High
0.04Volume Ratio
-1.39MNet Profit
1.51MShares
-0.5515EPS TTM
--Beta
-7.90%ROE
6.15052wk Low
15.57%Amplitude
--Gross Margin
2.79MMarket Cap
61.74Reward/Risk
49.37%Risk Rate
More news coming soon, stay tuned...
Apimeds Pharmaceuticals US Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-11.77/--
Revenue / Forecast
--/--
Apimeds Pharmaceuticals US Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolAPUS
Number of employees2
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Apimeds, Inc. | 34.32% |
| Inscobee, Inc. | 16.70% |
| Hemenway Trust Company LLC | 2.18% |
| Vanguard Capital Management, LLC | 0.76% |
| Shareholder Types | Proportion |
|---|---|
| Corporation | 52.13% |
| Bank and Trust | 2.18% |
| Individual Investor | 1.33% |
| Investment Advisor | 0.99% |
Related Instruments
+0.45%
-0.10%
+0.28%
+0.94%
+0.21%
+0.16%
+4.34%
+1.40%
-1.01%
+0.68%
+0.84%
-0.59%
+0.54%
+0.02%
-0.70%
+0.72%
+5.56%
+0.32%
-2.47%
-1.64%
FAQs
What is the current price of Apimeds Pharmaceuticals US Inc (APUS)?
The current price of Apimeds Pharmaceuticals US Inc (APUS) is 1.85.
What is the symbol of Apimeds Pharmaceuticals US Inc?
The ticker symbol of Apimeds Pharmaceuticals US Inc is APUS.
What is the 52-week high of Apimeds Pharmaceuticals US Inc?
The 52-week high of Apimeds Pharmaceuticals US Inc is 8.28.
What is the 52-week low of Apimeds Pharmaceuticals US Inc?
The 52-week low of Apimeds Pharmaceuticals US Inc is 1.64.
What is the market capitalization of Apimeds Pharmaceuticals US Inc?
The market capitalization of Apimeds Pharmaceuticals US Inc is 2.80M.
What is the Earnings Per Share (EPS TTM) of Apimeds Pharmaceuticals US Inc (APUS)?
The Earnings Per Share (EPS TTM) of Apimeds Pharmaceuticals US Inc (APUS) is -0.55.